Tarek Alkasabi, Chairman of Dallah Healthcare Co.
Tarek Alkasabi, Chairman of Dallah Healthcare Co., said the company entered the final quarter of 2025 on solid footing, anticipating its strongest performance of the year as expansion projects progress and operational efficiency continues to improve. 
In an interview with Argaam, Al Qasabi said the company’s performance during the first nine months was encouraging, particularly after expanding in the Eastern Province through the acquisition of Dallah Al Khobar and Dallah Al Ahsa hospitals. He added that the two hospitals are expected to generate revenue exceeding SAR 500 million, surpassing earlier projections.
The growth prospects remain strong across the company’s facilities, highlighting Dallah Al Khobar Hospital as one of the most promising. The company succeeded in reducing the hospital’s losses by 95% during the current quarter, while continuing to expand its operating capacity and services. The Chairman expressed confidence in the hospital’s bright future in serving patients in the Eastern Province.
He affirmed that these factors collectively support the company’s optimistic outlook for 2025, which is expected to be another record year for Dallah in terms of revenue, profit, and medical achievements.
Tarek Alkasabi, Chairman of Dallah Healthcare Co.
Tarek Alkasabi, Chairman of Dallah Healthcare Co., said the company entered the final quarter of 2025 on solid footing, anticipating its strongest performance of the year as expansion projects progress and operational efficiency continues to improve.
In an interview with Argaam, Al Qasabi said the company’s performance during the first nine months was encouraging, particularly after expanding in the Eastern Province through the acquisition of Dallah Al Khobar and Dallah Al Ahsa hospitals. He added that the two hospitals are expected to generate revenue exceeding SAR 500 million, surpassing earlier projections.
The growth prospects remain strong across the company’s facilities, highlighting Dallah Al Khobar Hospital as one of the most promising. The company succeeded in reducing the hospital’s losses by 95% during the current quarter, while continuing to expand its operating capacity and services. The Chairman expressed confidence in the hospital’s bright future in serving patients in the Eastern Province.
He affirmed that these factors collectively support the company’s optimistic outlook for 2025, which is expected to be another record year for Dallah in terms of revenue, profit, and medical achievements.
